NEW YORK, NY--(Marketwire - Dec 7, 2012) - Crystal Research Associates, LLC announced today that it has issued an Executive Informational Overview® (EIO) on Abakan Inc. (
Abakan (or "the Company") develops, manufactures, and markets advanced nanocomposite materials, innovative fabricated metal products, and engineered metal composites for applications in oil and gas, petrochemical, mining, aerospace and defense, energy, infrastructure, and processing industries. Abakan's portfolio includes high-speed large-area metal cladding technology, long-life nanocomposite anti-corrosion and anti-wear coating materials, and high-strength light-weight metal composites. Abakan states that its portfolio includes products with up to 80 times longer life, up to 40 times higher productivity, and favorable strength-to-weight ratios versus competing technologies.
The Company has introduced its metal coatings for metal asset protection and life-extension in the mining and oil and gas industries, and is working to scale-up and commercialize its metal cladding products for the oil and gas, oil sands, mining, and chemical industries. Abakan believes that the value proposition likely to drive adoption of its CermaClad™ corrosion- and wear-resistant clad products centers on being able to offer a more compelling cost-benefit trade-off than what presently exists. Abakan states that its clad products can be manufactured at up to 15 to 100 times higher productivity, with enhanced properties and longer life, at lower costs than competing technologies and products. Independent third-party testing at end users and laboratories has validated the value proposition offered by Abakan's technologies.
The Abakan group of companies has received numerous trade, industry, and technology recognitions, including as the top manufacturing technology globally by the Wall Street Journal, as the highest-ranked materials and only nanocomposite company on Forbes' 2011 list of "America's Most Promising Companies," five R&D 100 Awards from R&D Magazine, and a technology innovation award from National Institute of Standards and Technology, among others. Cumulative prior investment into the Company's core technologies has totaled over $50 million.
Be the first to hear about Crystal Research's new report releases and upcoming media coverage. Follow us on Twitter at https://twitter.com/crystalresearch or visit http://crystalra.com/blog/ for more coverage.
About Crystal Research Associates, LLC
Crystal Research Associates, LLC is an independent research firm that provides institutional-quality research on small- and mid-cap companies. The firm is led by veteran Wall Street sell-side analyst Jeffrey Kraws, who is well known by the international financial media for his years of work on Wall Street and for providing consistent award-winning analyses and developing long-term relationships on both the buy-side and sell-side. He has been consistently ranked on Wall Street among the Top Ten Analysts for pharmaceutical stock performance in the world for almost two decades as well as ranked as the Number One Stock Picker in the world for pharmaceuticals by Starmine and for estimates from Zacks. Additionally, Mr. Kraws has been 5-Star ranked for top biotechnology stock performance by Starmine.
Crystal Research Associates' unique and novel product, the Executive Informational Overview® (EIO), is free of investment ratings, target prices, and forward-looking financial models. The EIO presents a crystal clear, detailed report on a company (public or private) in a manner that is easily understood by the Wall Street financial community. The EIO details a company's product/technology/service offerings, market size(s), key intellectual property, leadership, growth strategy, competition, risks, financial statements, key events, and other such fundamental information. Crystal Research Associates has offices in New York City, West Palm Beach, Montréal, and Toronto. Crystal Research Associates has been compensated by the Company in cash of forty-two thousand, five hundred U.S. dollars as well as twenty thousand restricted shares and fifty thousand warrants for its services in creating the base report, for quarterly updates, and for printing costs.
Forward-Looking Safe Harbor Statement
Statements in this news release regarding future financial and operating results, potential applications of the Company's technology, opportunities for the Company, and any other statements about the future expectations, beliefs, goals, plans, or prospects expressed constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Any statements that are not statements of historical fact (including statements containing the words "will," "believes," "plans," "anticipates," "expects," "estimates," and similar expressions) should also be considered to be forward-looking statements. There are a number of important factors that could cause actual results or events to differ materially from those indicated by such forward-looking statements, including limited operating history, need for future capital, and economic conditions generally. Additional information on potential factors that could affect results and other risks and uncertainties are detailed from time to time in the Company's periodic reports, including forms filed with the SEC.
These statements, and other forward-looking statements, are not guarantees of future performance and involve risks and uncertainties. Crystal Research Associates assumes no obligation to update any of the forward-looking statements in this release.